Anterior: Treating the System, Not the Symptom

“Abdel, you’re already a doctor,” his father frowned. “Why would a doctor get an IT degree?”

For his parents, the decision to pursue computer science raised more questions than it answered. A science for computers? The man who troubleshot their Dell was hardly a scientist.

Though confused, their objections softened to shrugs. As Libyan refugees, uncertainty had been the only constant in their lives. The IT degree—“software engineering,” their son called it—would be another leap of faith that they would learn to embrace.

With his family’s blessing, Abdel graduated from UCL and spent his first year at Google. There, he first witnessed the expansive potential of new technologies and their applications in medicine. Software offered a more scalable approach to healthcare than treating patients one by one.

With the influx of AI products, the world had already begun building clinical tools that sharpen diagnostics, refine treatment, and push the boundaries of care. Despite these advances, Abdel noticed that much of healthcare’s administrative backbone—benefit verification, claims processing, and insurance—remained largely underdeveloped. Health plans held the keys to a $5 trillion market, along with the data necessary to meaningfully train AI systems. It was a promising and unsaturated space.

And yet, it proved a challenging market to access. While most companies were building for providers, where they could start small and grow over time, the insurer side offered no such path. Early success depended on winning business from multi-million-dollar insurers as an early-stage startup.

Abdel ventured into this space despite these challenges. By 2026, Anterior had raised $64 million in funding from Sequoia, NEA, Kinnevik, FPV, and ODDBIRD.

Anterior is a clinician-led company built on the premise that administrative workflows are crucial to healthcare’s vitality. By enabling health insurers to deploy AI automation within clinicians’ workflows, Anterior frees clinicians from administrative burdens, allowing them to focus on patients. The company isn’t simply the supplementation of AI in healthcare, but an amalgamation of medicine and artificial intelligence, working alongside medical professionals to ensure workflow quality.

Anterior’s impact has been nothing short of transformative. In its recent deployment with Geisinger Health Plan, cancer care approvals that previously took weeks now happen in roughly 155 seconds—often while the patient is still in the consultation room. In a field where seconds can make the difference between life and death, Anterior offers a way to save lives beyond scalpels and scrubs.

“Much of the industry uses AI to increase the speed of existing workflows—more money buys faster horses.” Anterior’s thesis isn’t built on buying faster horses, Abdel notes, but to rebuild the track they run on. The company believes the real opportunity lies in creating an entirely different operating model that embeds a continuous AI reasoning layer across healthcare, streamlining the patient’s entire care journey. When fully implemented, healthcare will be rapid, proactive, and feel as effortless as swiping a credit card to buy a coffee. With its most recent $40 million round, that goal is within reach—it seems the IT degree was worth it after all.